A dietary component, typically a lipid or medium-chain triglyceride (MCT), that is efficiently metabolized by the liver into ketone bodies, specifically beta-hydroxybutyrate, acetoacetate, and acetone. These ketone bodies serve as an alternative fuel for the brain and peripheral tissues when glucose is restricted. This nutritional strategy is clinically employed to induce or sustain a state of nutritional ketosis, influencing metabolic flexibility and hormonal substrate availability.
Origin
The term is rooted in metabolic physiology and the clinical application of the ketogenic diet, originally developed for managing refractory epilepsy. The ‘energy source’ refers to the substrate that directly drives the process of ketogenesis, bypassing the need for glucose as the primary fuel.
Mechanism
When carbohydrate intake is severely restricted, the liver initiates the beta-oxidation of fatty acids, leading to the accelerated production of acetyl-CoA, which is then converted into ketone bodies. Beta-hydroxybutyrate, in particular, acts as a signaling molecule, modulating gene expression, inhibiting histone deacetylases (HDACs), and influencing hormonal pathways related to insulin and ghrelin. This process impacts satiety, energy partitioning, and metabolic rate, often leading to improved insulin sensitivity.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.